European commission grants orphan medicinal product designation to Ultragenyx's burosumab June 29, 2016
Long-acting amylin analogues ZP-4982 and ZP-5461 improve glycemic control in diabetes model June 27, 2016
NIH committee recommends approval of Dimension Therapeutics' phase I/II study of DTX-301 June 23, 2016
Unique collaboration to translate stem cell discoveries into novel treatments for diabetes June 22, 2016
RSS